33 Participants Needed

Exercise Program for Endometrial Cancer Survivors

PL
JG
Overseen ByJess Gorzelitz, PHD, MS
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)
Approved in 1 JurisdictionThis treatment is already approved in other countries

Trial Summary

Do I need to stop taking my current medications to join the trial?

The trial does not specify if you need to stop taking your current medications, but you cannot participate if you are using semaglutide (a type of diabetes medication) or have used hormone replacement therapy in the last 3 months.

What data supports the effectiveness of this treatment for endometrial cancer survivors?

Research shows that exercise programs can improve quality of life and physical fitness in endometrial cancer survivors. A study found significant improvements in emotional and cognitive functioning, as well as a reduction in visceral fat, after participating in an exercise program.12345

Is the exercise program safe for endometrial cancer survivors?

Research suggests that home-based and community-based exercise programs can be safely prescribed to endometrial cancer survivors, although some may need supervised rehabilitation depending on their physical condition.24567

How does the 12-week home-based exercise treatment for endometrial cancer survivors differ from other treatments?

This treatment is unique because it is a home-based exercise program specifically designed for endometrial cancer survivors, focusing on improving quality of life and physical fitness without the need for a gym or medical facility. Unlike traditional treatments that may involve medication or surgery, this program emphasizes physical activity as a way to enhance overall health and well-being.12478

What is the purpose of this trial?

STRIVE Cardio is a 12-week exercise intervention study with the goal to improve functional fitness and cardiovascular health for women who have completed treatment for non-metastatic endometrial cancer within the last five years and are currently in remission. Measures will include a functional fitness test, carotid-femoral pulse wave velocity, brachial artery flow mediated dilation, and a blood draw. Participants will be provided resistance bands, a dumbbell, and a Fitbit to keep. Participants will be compensated $50 for each of their two in-person visits.

Research Team

JG

Jess Gorzelitz, PHD, MS

Principal Investigator

University of Iowa

Eligibility Criteria

The STRIVE Cardio trial is for English-speaking women aged 18-74 who have been treated for non-metastatic Type I endometrial cancer stages I-IIIc within the last five years and are now in remission. They must be able to use technology for telecoaching, pass a physical activity readiness test, get medical clearance if needed, and commit to the study's duration.

Inclusion Criteria

My doctor has cleared me to participate in this trial.
I am fluent in both spoken and written English.
I am willing and able to sign a consent form.
See 7 more

Timeline

Screening

Participants are screened for eligibility to participate in the trial

2 weeks
1 visit (in-person)

Pre-Intervention

Participants wear an accelerometer for one week prior to the exercise intervention

1 week

Exercise Intervention

Participants engage in a 12-week distance-based exercise program with virtual health coaching and in-person pre- and post-intervention measures

12 weeks
2 visits (in-person), weekly virtual coaching sessions

Follow-up

Participants are monitored for changes in vascular structure and function, and other health metrics post-intervention

1 week

Treatment Details

Interventions

  • 12-week home-based exercise intervention
Trial Overview This study tests a 12-week home-based exercise program designed to improve fitness and heart health in endometrial cancer survivors. Participants will receive resistance bands, a dumbbell, and a Fitbit. Their fitness levels and cardiovascular health will be assessed before and after the intervention.
Participant Groups
1Treatment groups
Experimental Treatment
Group I: 12-week Exercise InterventionExperimental Treatment1 Intervention
In this single-arm study, every participant will be enrolled in the 12-week distance-based exercise intervention. All participants will receive an exercise regimen and the necessary materials to complete and measure their exercise. All participants will receive weekly online heath coaching.

12-week home-based exercise intervention is already approved in United States for the following indications:

🇺🇸
Approved in United States as Exercise Intervention for:
  • Improvement of functional fitness and cardiovascular health in endometrial cancer survivors

Find a Clinic Near You

Who Is Running the Clinical Trial?

Jess S. Gorzelitz

Lead Sponsor

Trials
1
Recruited
30+

Findings from Research

An individualized exercise program for endometrial cancer patients, starting six weeks post-surgery, showed high feasibility with 41% consent rate and 86% attendance, and no adverse events reported.
Participants experienced significant improvements in quality of life, including emotional and cognitive functioning, as well as reductions in visceral fat and increased physical fitness, with maximum weight loss of 8.4 kg after six months.
Feasibility and Effectiveness of the Exercise Program in Endometrial Cancer; Feasibility and Acceptability Survivorship Trial (EPEC-FAST).Smits, A., Galaal, K., Winnan, S., et al.[2023]
In a study of 386 endometrial cancer survivors, those who met public health exercise guidelines and maintained a healthy body weight reported significantly better quality of life (QoL) compared to those who did not, highlighting the importance of physical activity and weight management.
Both exercise and body mass index (BMI) were found to be independently associated with QoL, suggesting that interventions aimed at increasing exercise and reducing excess weight could improve the well-being of endometrial cancer survivors.
Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors.Courneya, KS., Karvinen, KH., Campbell, KL., et al.[2006]
The 12-week home-based aerobic exercise and nutrition counseling program for obese endometrial cancer survivors showed a high adherence rate of 83.3%, indicating that such interventions can be feasible for this population.
Participants experienced significant reductions in fat mass and BMI, along with improved immune response as indicated by increased T-cell activity, although there were no significant changes in cardiorespiratory fitness or cardiovascular risk factors.
A Pilot Study of Home-Based Exercise and Personalized Nutrition Counseling Intervention in Endometrial Cancer Survivors.Schwartz, AR., Bartlett, DB., Johnson, JL., et al.[2022]

References

Feasibility and Effectiveness of the Exercise Program in Endometrial Cancer; Feasibility and Acceptability Survivorship Trial (EPEC-FAST). [2023]
Associations among exercise, body weight, and quality of life in a population-based sample of endometrial cancer survivors. [2006]
A Pilot Study of Home-Based Exercise and Personalized Nutrition Counseling Intervention in Endometrial Cancer Survivors. [2022]
Feasibility and acceptability of home-based strength training in endometrial cancer survivors. [2023]
The prescription or proscription of exercise in endometrial cancer care. [2018]
Feasibility of a physical activity intervention for obese, socioculturally diverse endometrial cancer survivors. [2017]
Feasibility and effectiveness of a lifestyle intervention program in obese endometrial cancer patients: a randomized trial. [2008]
Sexual health of endometrial cancer survivors before and after a physical activity intervention: A retrospective cohort analysis. [2018]
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top
Terms of Service·Privacy Policy·Cookies·Security